Early detection of MS treatment complication may improve survival
Monday, March 11, 2013 - 09:01
in Health & Medicine
The drug natalizumab is effective for treating multiple sclerosis (MS), but it increases the risk of a rare but potentially fatal brain infection called progressive multifocal leukoencephalopathy (PML). A new study suggests that early detection of PML may help improve survival and disability levels.